Universität zu Köln

Albrecht, Katinka t, Krueger, Klaus, Wollenhaupt, Juergen, Alten, Rieke, Backhaus, Marina, Baerwald, Christoph ORCID: 0000-0002-1406-3024, Bolten, Wolfgang, Braun, Juergen, Burkhardt, Harald, Burmester, Gerd R., Gaubitz, Markus, Gause, Angela, Gromnica-Ihle, Erika, Kellner, Herbert, Kuipers, Jens, Krause, Andreas, Lorenz, Hans-Martin, Manger, Bernhard ORCID: 0000-0003-2375-0069, Nuesslein, Hubert, Pott, Hans-Georg, Rubbert-Roth, Andrea, Schneider, Matthias, Specker, Christof ORCID: 0000-0003-2504-3229, Schulze-Koops, Hendrik, Tony, Hans-Peter, Wassenberg, Siegfried and Mueller-Ladner, Ulf (2014). German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. Rheumatol. Int., 34 (1). S. 1 - 10. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1437-160X

Full text not available from this repository.

Abstract

The German Society of Rheumatology approved new German guidelines for the sequential medical treatment of rheumatoid arthritis (RA) based on the European League Against Rheumatism (EULAR) recommendations for the management of RA published in 2010. An update of the EULAR systematic literature research was performed in Medline, Embase, and Cochrane databases. Meta-analyses, controlled trials, cohort studies, and registry data addressing traditional and biologic disease-modifying antirheumatic drugs, glucocorticoids, and treatment strategies published between January 2009 and August 2011 were included. Two reviewers independently evaluated and compared the additional data that had been published after the time limit set by the EULAR recommendations. A national guideline working group developed an adapted set of recommendations. The new German guidelines were accepted by vote using an informal Delphi approach. Twelve recommendations and the resulting updated treatment algorithm were developed and approved as a practical orientation for rheumatologists. These recommendations are based on a successive treatment with traditional and biologic disease-modifying drugs depending on the individual progress of the disease and distinct patient characteristics. The German guidelines have been developed on the basis of the internationally well-recognized EULAR recommendations. In addition, more recent evidence from a systematic literature research was considered. They have been developed and approved by a group of national experts aiming at guidance for rheumatologists to reach best medical practice.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Albrecht, Katinka t UNSPECIFIED UNSPECIFIED UNSPECIFIED Krueger, Klaus UNSPECIFIED UNSPECIFIED UNSPECIFIED Wollenhaupt, Juergen UNSPECIFIED UNSPECIFIED UNSPECIFIED Alten, Rieke UNSPECIFIED UNSPECIFIED UNSPECIFIED Backhaus, Marina UNSPECIFIED UNSPECIFIED UNSPECIFIED Baerwald, Christoph UNSPECIFIED orcid.org/0000-0002-1406-3024 UNSPECIFIED Bolten, Wolfgang UNSPECIFIED UNSPECIFIED UNSPECIFIED Braun, Juergen UNSPECIFIED UNSPECIFIED UNSPECIFIED Burkhardt, Harald UNSPECIFIED UNSPECIFIED UNSPECIFIED Burmester, Gerd R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Gaubitz, Markus UNSPECIFIED UNSPECIFIED UNSPECIFIED Gause, Angela UNSPECIFIED UNSPECIFIED UNSPECIFIED Gromnica-Ihle, Erika UNSPECIFIED UNSPECIFIED UNSPECIFIED Kellner, Herbert UNSPECIFIED UNSPECIFIED UNSPECIFIED Kuipers, Jens UNSPECIFIED UNSPECIFIED UNSPECIFIED Krause, Andreas UNSPECIFIED UNSPECIFIED UNSPECIFIED Lorenz, Hans-Martin UNSPECIFIED UNSPECIFIED UNSPECIFIED Manger, Bernhard UNSPECIFIED orcid.org/0000-0003-2375-0069 UNSPECIFIED Nuesslein, Hubert UNSPECIFIED UNSPECIFIED UNSPECIFIED Pott, Hans-Georg UNSPECIFIED UNSPECIFIED UNSPECIFIED Rubbert-Roth, Andrea UNSPECIFIED UNSPECIFIED UNSPECIFIED Schneider, Matthias UNSPECIFIED UNSPECIFIED UNSPECIFIED Specker, Christof UNSPECIFIED orcid.org/0000-0003-2504-3229 UNSPECIFIED Schulze-Koops, Hendrik UNSPECIFIED UNSPECIFIED UNSPECIFIED Tony, Hans-Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Wassenberg, Siegfried UNSPECIFIED UNSPECIFIED UNSPECIFIED Mueller-Ladner, Ulf UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-451403
DOI:	10.1007/s00296-013-2848-3
Journal or Publication Title:	Rheumatol. Int.
Volume:	34
Number:	1
Page Range:	S. 1 - 10
Date:	2014
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1437-160X
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language EULAR RECOMMENDATIONS; DOUBLE-BLIND; METHOTREXATE; MANAGEMENT; REMISSION; THERAPY; COMBINATION; 2-YEAR; CYCLOSPORINE; LEFLUNOMIDE Multiple languages Rheumatology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/45140